Cato, Merge extend relationship

Full-service CRO Cato Research has added etrials, a proprietary EDC solution from Merge Healthcare, to its existing Merge infrastructure. The addition was done via the solution provider's technology transfer program and extends the relationship between the two companies by five years.

Cato knows e-clinical technology and the FDA. The CRO's director for regulatory operations, Evan Richardson, has written recently about tech errors to avoid in electronic Common Technical Documents and how to make eCTD submissions reviewer friendly.

Cato will use the SaaS etrials solution for custom client studies. Companion solutions for interactive voice response and electronic patient reported outcomes can be integrated with the EDC system. The Merge solutions are licensed via subscription or on a study basis.

Merge last month closed on its merger with imaging IT specialist Amicas, expanding its reach across care settings--from outpatient imaging sites to radiology, cardiology, and enterprise solutions serving the hospital market.

- see the release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.